Translate

Tuesday, January 12, 2010

Suven gets two patents from China and Russia

City-based biopharmaceutical company Suven Life Sciences announced on Tuesday that two product patents were granted in China and Russia to two of their new chemical entities (NCEs) for treatment of neurodegenerative diseases. These are valid until 2023 and 2024 respectively.

These are being developed as therapeutic agents for treatment of cognitive impairment associated with Alzheimer’s disease, attention deficient hyperactivity disorder, Huntington’s, Parkinson and schizophrenia.

Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II, said its chief executive officer Venkat Jasti.

The Company has six therapeutic drug candidates currently in pre-clinical stage, according to a filing on the Bombay Stock Exchange.

Its stock is traded at Rs 30, up 5.44 per cent from the previous close of Rs 30.35 on the BSE.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Economic Event Calendar

GMT+5:30 Event Vol. Actual Consensus Previous
Wednesday, Jun 18
11:30 Consumer Price Index (MoM) 3 0.2% 0.2% 1.2%
11:30 Retail Price Index (MoM) 2 0.2% 1.7%
11:30 Retail Price Index (YoY) 2 4.3% 4.3% 4.5%
14:00 DCLG House Price Index (YoY) 1 3.5% 7.0% Revised from 6.4%
16:30 MBA Mortgage Applications 1 -2.6% 12.5%
18:00 Building Permits Change 1 -4.0% Revised from -4.7%
18:00 Housing Starts Change 1 1.6%
18:00 Housing Starts (MoM) 2 1.360M 1.361M
18:00 Building Permits (MoM) 2 1.430M 1.422M Revised from 1.412M
18:00 Continuing Jobless Claims 1 1.940M 1.956M
Economic Calendar >> Add to your site

Best Mutual Funds

Recent Posts

Search This Blog

IPO's Calendar

Market Screener

NSE BSE Tiker

Custom Pivot Calculator

Popular Posts

Market & MF Screener